(Q39619138)

13 September 2017

title

Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds (English)

1 reference

13 September 2017

1 reference

Anna K Renfrew

2

0 references

Gregory S Smith

object named as

Gregory S Smith

6

0 references

Paul Dyson

object named as

Paul J Dyson

4

0 references

Bruno Therrien

5

object named as

Bruno Therrien

1 reference

13 September 2017

Preshendren Govender

1

1 reference

13 September 2017

Catherine M Clavel

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

17 December 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

40

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

1158-1167

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Bioorganometallic chemistry--from teaching paradigms to medicinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Exploring the cellular accumulation of metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Antitumour metal compounds: more than theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Ruthenium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Arene ruthenium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Ruthenium polypyridyl complexes and their modes of interaction with DNA: is there a correlation between these interactions and the antitumor activity of the compounds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Modifying the structure of dinuclear ruthenium complexes with antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

The "complex-in-a-complex" cations [(acac)2M subset Ru6(p-iPrC6H4Me)6(tpt)2(dhbq)3]6+: A trojan horse for cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Anticancer activity of opened arene ruthenium metalla-assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Control of tumour vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Synthesis and cytotoxic activities of chloropyridylimineplatinum(II) and chloropyridyliminecopper(II) surface-functionalized poly(amidoamine) dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

The synthesis and catalytic activity of a first-generation poly(propylene imine) pyridylimine palladium metallodendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Iminopyridyl-palladium dendritic catalyst precursors: evaluation in Heck reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Ruthenium porphyrin compounds for photodynamic therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Arene ruthenium(II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium(III) trichloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

21 January 2018

A short history of SHELX

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

New software for searching the Cambridge Structural Database and visualizing crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0DT00761G

Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.698

8 July 2023

Identifiers

DOI

10.1039/C0DT00761G

1 reference

13 September 2017

1 reference